CounterPath (NASDAQ:CPAH) Stock Crosses Below 200 Day Moving Average of $1.39

CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.39 and traded as low as $1.15. CounterPath shares last traded at $1.15, with a volume of 100 shares.

Separately, ValuEngine raised CounterPath from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.

The company has a fifty day moving average of $1.16 and a 200 day moving average of $1.39. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 1.64.

A hedge fund recently raised its stake in CounterPath stock. Wedbush Securities Inc. increased its position in CounterPath, Corp. (NASDAQ:CPAH) (TSE:CCV) by 72.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,192 shares of the software maker’s stock after buying an additional 11,874 shares during the period. Wedbush Securities Inc. owned 0.47% of CounterPath worth $32,000 at the end of the most recent quarter. Institutional investors own 1.24% of the company’s stock.

About CounterPath (NASDAQ:CPAH)

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite, which enables consumers and business users to make voice over Internet protocol (VoIP) audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and X-Lite, a standards-based VoIP softphone application that runs on desktop computers.

Featured Article: Fundamental Analysis

Receive News & Ratings for CounterPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath and related companies with's FREE daily email newsletter.